SUN PHARMA ADV. RES. | EKI ENERGY SERVICES | SUN PHARMA ADV. RES./ EKI ENERGY SERVICES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -21.9 | -6.5 | - | View Chart |
P/BV | x | 15.5 | 1.9 | 831.7% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
SUN PHARMA ADV. RES. EKI ENERGY SERVICES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
SUN PHARMA ADV. RES. Mar-23 |
EKI ENERGY SERVICES Mar-23 |
SUN PHARMA ADV. RES./ EKI ENERGY SERVICES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 306 | 2,964 | 10.3% | |
Low | Rs | 161 | 512 | 31.4% | |
Sales per share (Unadj.) | Rs | 7.4 | 467.6 | 1.6% | |
Earnings per share (Unadj.) | Rs | -6.9 | 43.5 | -15.8% | |
Cash flow per share (Unadj.) | Rs | -6.5 | 44.9 | -14.5% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 15.8 | 187.0 | 8.5% | |
Shares outstanding (eoy) | m | 324.52 | 27.51 | 1,179.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 31.7 | 3.7 | 852.2% | |
Avg P/E ratio | x | -34.0 | 40.0 | -85.0% | |
P/CF ratio (eoy) | x | -35.9 | 38.7 | -92.8% | |
Price / Book Value ratio | x | 14.7 | 9.3 | 158.7% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 75,630 | 47,814 | 158.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,070 | 442 | 242.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 2,388 | 12,864 | 18.6% | |
Other income | Rs m | 109 | 129 | 84.5% | |
Total revenues | Rs m | 2,497 | 12,993 | 19.2% | |
Gross profit | Rs m | -2,141 | 1,624 | -131.8% | |
Depreciation | Rs m | 118 | 40 | 296.1% | |
Interest | Rs m | 76 | 57 | 134.9% | |
Profit before tax | Rs m | -2,226 | 1,656 | -134.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 460 | 0.0% | |
Profit after tax | Rs m | -2,226 | 1,196 | -186.0% | |
Gross profit margin | % | -89.6 | 12.6 | -710.3% | |
Effective tax rate | % | 0 | 27.8 | -0.0% | |
Net profit margin | % | -93.2 | 9.3 | -1,002.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 4,550 | 7,042 | 64.6% | |
Current liabilities | Rs m | 1,789 | 1,278 | 140.0% | |
Net working cap to sales | % | 115.6 | 44.8 | 258.0% | |
Current ratio | x | 2.5 | 5.5 | 46.2% | |
Inventory Days | Days | 815 | 29 | 2,817.1% | |
Debtors Days | Days | 500 | 98 | 510.6% | |
Net fixed assets | Rs m | 3,752 | 1,842 | 203.7% | |
Share capital | Rs m | 325 | 275 | 118.0% | |
"Free" reserves | Rs m | 4,803 | 4,869 | 98.6% | |
Net worth | Rs m | 5,128 | 5,144 | 99.7% | |
Long term debt | Rs m | 0 | 225 | 0.0% | |
Total assets | Rs m | 8,301 | 8,883 | 93.4% | |
Interest coverage | x | -28.2 | 30.3 | -93.0% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.3 | 1.4 | 19.9% | |
Return on assets | % | -25.9 | 14.1 | -183.6% | |
Return on equity | % | -43.4 | 23.3 | -186.6% | |
Return on capital | % | -41.9 | 31.9 | -131.4% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 1,317 | 13,804 | 9.5% | |
Fx outflow | Rs m | 2,662 | 7,652 | 34.8% | |
Net fx | Rs m | -1,345 | 6,152 | -21.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -691 | 1,413 | -48.9% | |
From Investments | Rs m | -5,483 | -1,679 | 326.5% | |
From Financial Activity | Rs m | 6,168 | 528 | 1,167.2% | |
Net Cashflow | Rs m | -6 | 262 | -2.4% |
Indian Promoters | % | 65.7 | 73.4 | 89.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 3.9 | 0.1 | 2,785.7% | |
FIIs | % | 3.2 | 0.1 | 2,314.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 34.3 | 26.6 | 129.2% | |
Shareholders | 102,743 | 68,853 | 149.2% | ||
Pledged promoter(s) holding | % | 2.8 | 0.0 | - |
Compare SUN PHARMA ADV. RES. With: LATENT VIEW ANALYTICS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | SUN PHARMA ADV. RES. | EKI ENERGY SERVICES |
---|---|---|
1-Day | -5.00% | 0.24% |
1-Month | -35.08% | 5.23% |
1-Year | 25.63% | -27.00% |
3-Year CAGR | 11.79% | 61.03% |
5-Year CAGR | 7.80% | 56.86% |
* Compound Annual Growth Rate
Here are more details on the SUN PHARMA ADV. RES. share price and the EKI ENERGY SERVICES share price.
Moving on to shareholding structures...
The promoters of SUN PHARMA ADV. RES. hold a 65.7% stake in the company. In case of EKI ENERGY SERVICES the stake stands at 73.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SUN PHARMA ADV. RES. and the shareholding pattern of EKI ENERGY SERVICES.
Finally, a word on dividends...
In the most recent financial year, SUN PHARMA ADV. RES. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
EKI ENERGY SERVICES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of SUN PHARMA ADV. RES., and the dividend history of EKI ENERGY SERVICES.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.